The post Eli Lilly to build $5 billion Virginia manufacturing facility appeared on BitcoinEthereumNews.com.

Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments – the first in a string of new planned U.S. investments by the drugmaker.  The company announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020. Eli Lilly said it will announce the three remaining U.S. sites this year, and expects to begin making medicines at all four facilities within five years.  Drugmakers have been scrambling to boost their production in the U.S. as President Donald Trump threatens to clamp down on the industry with tariffs on pharmaceuticals imported into the country. Trump has said those levies will encourage companies to re-shore production after domestic drug manufacturing shrunk dramatically over the past decade.  In a release Tuesday, Eli Lilly said the new Virginia plant will develop active ingredients for cancer and autoimmune drugs, along with other advanced treatments. It will be the company’s first dedicated active ingredient and drug product site for its bioconjugate platform and portfolio of monoclonal antibody drugs.  Eli Lilly said the facility will particularly boost domestic manufacturing of targeted treatments called antibody drug conjugates – a type of bioconjugate that links a monoclonal antibody to a toxic “payload” to kill cancer cells. Eli Lilly is among several pharmaceutical companies developing or currently marketing those drugs, which drugmakers are also studying in autoimmune conditions and other diseases.  “This is new capacity to allow for pipeline growth. We’ve got a number of new assets coming that will use both biologics, but also these…

---

Filed under: News - @ September 16, 2025 2:37 pm